Company / Shareholders' Equity
PROCEPT BioRobotics Corp Shareholders' Equity History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$365.9M
FY2025
5-year range
$197.1M / $402.2M
FY2021-FY2025
Trend
-9.0%
vs FY2024
Sector context
#121 of 162
Health Care
What the data says
PROCEPT BioRobotics Corp's shareholders' equity of $366M is lower than 75% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 6 years, ranging from -$183M in FY2020 to $402M in FY2024.
Based on SEC 10-K filings.
$366M in FY2025 with a 3-year CAGR of +22.9%.
Improved from $281M to $366M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +22.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 162This company $365.9M Sector average $5.4B
▼
-93.2% below sector average
Key checks
Key Insights
- 3-year CAGR of +22.9%, indicating consistent growth.
- In FY2025, shareholders' equity decreased 9.0% year-over-year.
- Ranks #121 out of 162 companies in the Health Care sector.
- Peak shareholders' equity was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $365.9M | -9.0% |
| FY2024 | $402.2M | +43.3% |
| FY2023 | $280.8M | +42.5% |
| FY2022 | $197.1M | -26.2% |
| FY2021 | $267.1M | +246.0% |
| FY2020 | -$182.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026